LRCX

Lam Research
D

LRCX

Arincen83/100B

Lam Research executives and insider trading

Timothy Archer sold 234,700 shares for 55.97M USD in 5 sales over the last twelve months, the last on 23 October 2026, and bought none on the open market.

Over the last twelve months Lam Research's insiders sold 639,813 shares for 167.58M USD in 65 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
65
Shares sold
639,813
Value sold
167.58M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
174.42K USD
0
1 month
7.30M USD
0
3 months
38.81M USD
0
6 months
107.13M USD
0
1 year
167.58M USD
601.91 USD
2 years
183.15M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Timothy Archer CEOPresident, Chief Executive Officer & Director59234,70055.97M USD—23 Oct 20261,107,366
Eric Brandt Director—144,00047.03M USD—12 Jun 2026198,905
Douglas R. Bettinger Executive Vice President & Chief Financial Officer59130,46626.53M USD—4 Mar 20261,131,762
Seshasayee Varadarajan Executive Vice President & Chief Operating Officer5159,75017.41M USD—2 Sept 2026233,026
Neil J. Fernandes Senior Vice President of Global Customer Operations5925,8297.01M USD—1 Jun 202658,470
Abhijit Y Talwalkar Director—18,2826.12M USD—13 Jul 202687,142
Ava Harter Senior Vice President, Chief Legal Officer & Secretary5616,5104.33M USD—31 Aug 202642,462
Bethany Mayer Director—10,2763.18M USD—2 Nov 2026916

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
2 Nov 2026Bethany MayerSale719242.59174.42K USD916Form 4
23 Oct 2026Timothy ArcherSale31,400227.027.13M USD1,075,966Form 4
9 Sept 2026Timothy ArcherSale30,000319.269.58M USD1,075,966Form 4
9 Sept 2026Bethany MayerSale9,557314.743.01M USD20,995Form 4
2 Sept 2026Seshasayee VaradarajanSale12,270291.323.57M USD205,546Form 4
2 Sept 2026Seshasayee VaradarajanSale20,000291.325.83M USD205,546Form 4
2 Sept 2026Seshasayee VaradarajanSale27,480291.328.01M USD205,546Form 4
31 Aug 2026Ava HarterSale5,000302.461.51M USD42,462Form 4
6 Aug 2026Timothy ArcherSale30,000300.009.00M USD1,075,966Form 4
13 Jul 2026Abhijit Y TalwalkarSale18,282335.006.12M USD87,142Form 4
2 Jul 2026Timothy ArcherSale30,000390.0111.70M USD1,075,966Form 4
12 Jun 2026Eric BrandtSale300355.71106.71K USD198,905Form 4
12 Jun 2026Eric BrandtSale1,393357.24497.64K USD197,512Form 4
12 Jun 2026Eric BrandtSale1,100357.98393.78K USD196,412Form 4
12 Jun 2026Eric BrandtSale3,828359.081.37M USD192,584Form 4

Common questions about Lam Research's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.